The product is available in all 26 Curaleaf dispensaries across the state.
The company already sells medical cannabis tablets in New Jersey, Maryland, Connecticut, and New York, and works on reaching other states.
"Knowing that our premium quality medical cannabis products allow so many of our patients to live life well, we are always looking for alternative administration methods to meet patients' needs," Joe Lusardi, Curaleaf CEO, said in a statement. "We are proud to be the first to offer Florida's patients the option of medical cannabis tablets."
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
The company said the tablets are a more convenient form of medication, providing ease of use and slow-acting; they are mint-flavored and packed in child-proof containers.
Shares of Curaleaf were up 0.86% at $7.49 Friday morning.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter
See more from Benzinga
- Curaleaf Expands Footprint, Closes Glendale Greenhouse Acquisition
- Curaleaf Opens 25th Dispensary In Florida
- Curaleaf Holdings To Buy Grassroots In 5M Deal
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.